Ambien vs Belsomra
How zolpidem and suvorexant compare for insomnia, an older GABA-based z-drug and a newer orexin blocker.
How they're similar
Zolpidem and suvorexant do not work the same way, but they do have several things in common as sleep medications.
- Both are prescription sleep medications.
- Both are Schedule IV controlled substances, a federal category for medications with accepted medical use and a recognized potential for misuse and dependence.
- Both work the same night and are taken right before bed, with no weeks-long wait for the effect to build.
- Both need a full night of sleep available afterward, generally about 7 to 8 hours.
- Both can cause next-day drowsiness that can affect driving even when a person feels fine.
- Both can cause complex sleep behaviors, meaning doing things such as walking, driving, or eating while not fully awake, with no memory of it afterward.
- For both, cognitive behavioral therapy for insomnia, often shortened to CBT-I, is the first-line treatment for chronic insomnia.
That shared list covers the basics of how these drugs are used. In how they work, what they treat best, and how risky they are, they part ways. Knowing those differences is the point of comparing them.
How they differ
The differences here are real and go to the core of each drug. They cover mechanism, warnings, what each treats, dependence risk, and cost. The table below sums up the core points, with more detail underneath.
| Zolpidem (Ambien) | Suvorexant (Belsomra) | |
|---|---|---|
| Drug class | Z-drug (nonbenzodiazepine hypnotic) | Orexin receptor antagonist |
| How it works | Enhances GABA, broadly quieting brain activity | Blocks orexin, turning down the wakefulness signal |
| FDA boxed warning | Yes, for complex sleep behaviors | No boxed warning |
| What it treats best | Mainly trouble falling asleep | Both falling asleep and staying asleep |
| Dependence risk | Real risk of dependence and tolerance | Considered low, though still a controlled substance |
| Cost | Inexpensive long-standing generic | Newer, mainly brand-name, tends to cost more |
The first difference is mechanism, and it is the core one. Zolpidem enhances GABA, the brain's main calming chemical messenger, which broadly quiets brain activity and promotes sleep. Suvorexant works from the opposite direction. It blocks orexin, the brain chemical that promotes wakefulness, so it turns down the "stay awake" signal rather than sedating the brain broadly. These are two different routes to the same goal of sleep.
The second difference is the boxed warning. Zolpidem carries an FDA boxed warning, the agency's strongest, about complex sleep behaviors. Suvorexant does not carry a boxed warning. Complex sleep behaviors do appear in suvorexant's labeling, but as a regular labeled warning rather than a boxed one. Both drugs can cause these behaviors, so the practical caution is similar, but the formal warning level differs.
The third difference is what each treats best. Zolpidem immediate-release is aimed mainly at trouble falling asleep. Suvorexant is approved for both trouble falling asleep and trouble staying asleep, so it covers more of the night.
The fourth difference is dependence risk. Zolpidem carries a real risk of dependence and tolerance, especially with nightly use over long stretches, though the risk is generally lower than with benzodiazepines. Suvorexant's dependence and withdrawal risk is considered low, and rebound insomnia is less of a concern with it, though it is still a Schedule IV controlled substance and is used thoughtfully.
Suvorexant also has some distinctive labeled effects that zolpidem does not share in the same way. These include sleep paralysis, a brief inability to move or speak while falling asleep or waking up, brief leg weakness similar to mild cataplexy, and vivid dream-like experiences when falling asleep or waking. Because of how it works on the same brain system disrupted in narcolepsy, suvorexant should not be used by people who have narcolepsy.
Cost is the last difference. Zolpidem is an inexpensive long-standing generic. Suvorexant is newer and available mainly as the brand name Belsomra, so it tends to cost more. Suvorexant is one of a small newer group of orexin blockers, alongside lemborexant and daridorexant.
Side effects compared
The side effects of these two are different in character. Zolpidem's common effects include drowsiness, dizziness, next-day grogginess, headache, a foggy or "drugged" feeling for some people, and dry mouth. With regular use it can cause dependence and tolerance, and stopping after regular use can bring rebound insomnia.
Suvorexant's common effects include next-day drowsiness or a groggy morning feeling, headache, dizziness, unusual or vivid dreams, and dry mouth. Its dependence and withdrawal risk is considered low, so rebound insomnia is less of a concern than with zolpidem. Suvorexant also has the distinctive labeled effects noted above: sleep paralysis, brief leg weakness, and dream-like experiences while falling asleep or waking. Worsening of depression or new thoughts of self-harm can occur with suvorexant, and any such change should prompt prompt contact with the prescriber. With either drug, next-day drowsiness can affect driving, and older adults are more sensitive to both. If a side effect is severe, or it is not improving, that is a conversation to have with the prescriber rather than a reason to stop on your own.
Sleep, weight, and sexual effects
Both drugs are essentially weight-neutral. Neither tends to change appetite or body weight the way some psychiatric medications can. Sexual side effects are not a defining feature of either one, and neither causes the reduced sex drive or delayed orgasm linked to antidepressants. The one point worth noting on sexual effects is complex sleep behaviors, which both drugs can cause. Rarely, those can include sexual activity done while not fully awake and with no memory of it afterward.
On sleep itself, the difference reflects how each drug works. Zolpidem is aimed mainly at falling asleep, and its short action means less drug in the body by morning. Suvorexant covers both falling asleep and staying asleep, and some people notice vivid or unusual dreams with it. With either drug, a full night of sleep available afterward reduces next-day grogginess. Anything bothersome in any of these areas is worth raising with a prescriber.
Why a clinician might choose one over the other
The two suit different situations, so the choice usually follows the goal and the person's history.
A clinician might choose zolpidem for short-term trouble falling asleep, when low cost matters, or when a long track record is reassuring. Zolpidem has been used for decades, comes in several flexible forms, and is among the lower-cost sleep medications. Its dependence risk is the main reason it is used short-term rather than indefinitely.
A clinician might choose suvorexant when staying asleep is also a problem, since it is approved for both parts of the night. It can be a good fit when dependence risk should be kept as low as possible, for instance for someone where that is a particular concern, or when z-drugs have not worked or are not a good fit. Its higher cost is the main downside, and it should not be used by people with narcolepsy.
For either drug, the bigger question is often whether a nightly sleeping pill is the right tool at all, compared with CBT-I. Neither is a long-term solution for insomnia on its own.
The bottom line
Zolpidem is an older z-drug that enhances GABA to broadly quiet the brain. It is inexpensive, has a long track record, and is aimed mainly at falling asleep, but it carries a boxed warning and a real risk of dependence. Suvorexant is a newer medication that blocks orexin, the wakefulness signal, and is approved for both falling asleep and staying asleep, with low dependence risk and no boxed warning, though it costs more. They are built around different ideas of how to produce sleep. The right choice depends on the situation and is made with a prescriber.
Common questions
How is Belsomra different from Ambien? They work in opposite directions. Zolpidem enhances GABA, broadly quieting brain activity to bring on sleep. Suvorexant blocks orexin, the brain's wakefulness signal, so it turns down the "stay awake" side instead of sedating broadly. Suvorexant is also approved for both falling asleep and staying asleep, while standard zolpidem is aimed mainly at falling asleep.
Which one is less habit-forming? Suvorexant. Its dependence and withdrawal risk is considered low, and rebound insomnia is less of a concern with it. Zolpidem carries a real risk of dependence and tolerance, especially with nightly use over long periods. Both are still Schedule IV controlled substances and are used thoughtfully.
Does Belsomra have a boxed warning like Ambien? No. Zolpidem carries an FDA boxed warning for complex sleep behaviors. Suvorexant does not carry a boxed warning. Complex sleep behaviors still appear in suvorexant's labeling, but as a regular labeled warning rather than a boxed one, so both drugs can cause them.
Why does Belsomra cost more? Suvorexant is a newer medication and is available mainly as the brand name Belsomra. Zolpidem has been a generic for many years, which makes it inexpensive. The cost difference is one reason a prescriber weighs both options for a given situation.
Sources
This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.
Managing a medication needs a prescriber
Any psychiatric medication has to be started and adjusted by a clinician who can follow you over time. If you don't have a prescriber, our guides section explains the options, including in-person care and telepsychiatry, and how to choose between them.